✦ LIBER ✦

282 oral A phase III study of high dose radiation therapy with or without cetuximab in patients with locoregionally advanced squamous cell carcinoma of the head and neck

Book ID: 119515760
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 128 KB
Volume: 73
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(04)82149-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck

✍ Degardin, M.; Domenge, C.; Cappelaere, P.; Luboinski, B.; Navarrete, M.S.; Scott 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 257 KB

High-dose intra-arterial cisplatin and c

High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase II study

✍ William F. Regine; Joseph Valentino; William John; Gayle Storey; David Sloan; Da 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

Hyperfractionated radiation therapy with

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vask 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 12 KB

A phase II study of pirarubicin in patie

A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma

✍ P. H. M. De Mulder, P. Cappelaere, F. Cognetti… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 296 KB

Phase II study of weekly high-dose cispl

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck

✍ A.S.T. Planting; P.H.M. de Mulder; A. de Graeff; J. Verweij 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 694 KB

A multicenter phase 1 study of PX-866 an

A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck

✍ Bowles, Daniel W.; Senzer, Neil; Hausman, Diana; Peterson, Scott; Vo, Alex; Walk 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 266 KB